M. Chacon

发表

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

D. Furman, C. Yee, O. Lantz, 2008, Journal of Translational Medicine.

Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina

L. Paganini, Mora Amat, M. Chacón, 2022, World journal of clinical oncology.

Adjuvant chemotherapy in soft tissue sarcoma (STS): A meta-analysis of published data

R. Chacón, M. Chacón, J. O'Connor, 2008 .

Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair–Related Genes

R. Chacón, Mora Amat, F. Coló, 2022, JCO precision oncology.

Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic

J. Blay, R. Maki, E. de Álava, 2020, The oncologist.

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

C. Antonescu, J. Desai, J. Fletcher, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Uncommon Subtypes of Malignant Melanomas: A Review Based on Clinical and Molecular Perspectives

M. Chacón, F. Waisberg, M. Angel, 2020, Cancers.

RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

F. Petracci, A. Pini, M. Chacon, 2020, Ecancermedicalscience.

Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA

M. Heinrich, C. Corless, J. Hornick, 2013, Cancer medicine.

Official French SARS-CoV-2 guidelines for cancer patients, a triage solution with precision medicine

M. Chacón, J. O'Connor, Federico Esteso, 2020, Colorectal cancer.

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics

O. Smaletz, Ludmila de Oliveira Koch, F. Cardoso, 2016, OncoTargets and therapy.

Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina

Yamil D. Mahmoud, J. O. O Connor, C. Pupareli, 2021, Ecancermedicalscience.

CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.

M. Chacón, E. Roca, F. Loria, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.

C. Pupareli, M. Chacón, E. Roca, 2015, Future oncology.

PET in patients with metastatic gastrointestinal stromal tumors

C. Pupareli, M. Chacón, E. Roca, 2015 .

Systemic Therapy for Melanoma: ASCO Guideline Update

V. Sondak, P. Ascierto, M. Atkins, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report

N. Reguart, C. Pupareli, M. R. Girotti, 2022, JTO clinical and research reports.

Appraising the quality of meta-analysis for breast cancer treatment in the adjuvant setting: A systematic review.

I. Hirsch, M. Chacón, P. Mandó, 2021, Cancer treatment and research communications.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, Ludmila V. Danilova, David C. Smith, 2016, Journal of Translational Medicine.

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review

J. Utikal, Y. Najjar, C. Robert, 2019, Melanoma management.

Analysis of Adverse Events Attribution and Reporting in Cancer Clinical Trials: A Systematic Review.

M. Chacón, P. Mandó, F. Waisberg, 2021, Critical reviews in oncology/hematology.

Non-surgical management of rectal cancer. Series of 68 cases, long follow up in two leading centres in Argentina.

J. Mariani, M. Chacón, S. Iseas, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

D. Furman, C. Yee, O. Lantz, 2008, Journal of Translational Medicine.

First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study

M. Rizzo, A. Sola, M. Chacón, 2022, World journal of clinical oncology.

Cisplatin, Docetaxel and Cetuximab (TPEx) as First-line Treatment for Patients With Recurrent or Metastatic Head and Neck Cancer: A Multicenter Real-World Study

M. Rizzo, A. Sola, M. Chacón, 2020 .

Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres

J. Zarbá, M. Chacón, M. Angel, 2022, Ecancermedicalscience.

Short-course radiotherapy for rectal cancer: real-world evidence in Argentina

F. Waisberg, J. O'Connor, D. Enrico, 2023, Ecancermedicalscience.